Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 440 (TSX: $VLNS.TO) (NASDAQ: $GNLN) (CSE: $CURA.C) (TSX: $HMMJ.TO)
Delta, Kelowna, BC, July 10, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/07131VLNS-GNLN-CURA-HMMJ.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) announced its participation in a Medical Cannabis Real-World Evidence Study led by Dr. Hance Clarke of the University Health Network (UHN) in Toronto, Canada. The study will explore the therapeutic effects of medical cannabis in adults with chronic pain, sleep, or anxiety issues, and will leverage the blockchain secure technology of the Medical Cannabis by Shoppers online product portal of both tested and verified cannabis products.
The Valens Company has contributed to the study with the inclusion of Nūance, its exclusive brand of premium cannabis oil developed by the Company for Medical Cannabis by Shoppers. As part of the study, the Nūance line of THC and CBD oils will be tested, with the verified results on each batch made available through the Medical Cannabis by Shoppers portal for each physician and patient. Patients will be able to identify the contents of their product through the platform, including potency levels of THC and CBD, and confidently rely on the data to ensure batch-to-batch consistency and quality. The goal of this study is to provide physicians, pharmacists, and patients with confidence in medicinal cannabis products as an alternate treatment for various ailments, including pain relief.
"Nūance oils are developed exclusively for Shoppers Drug Mart with medical cannabis patients at the core. To be able to participate in this real-world study and have the opportunity to understand how our products could be used as a treatment is an exciting step in the right direction for us," said Tyler Robson, Chief Executive Officer of The Valens Company. "With insights and data from this study, we look forward to further advancing our commitment to developing and testing the highest-quality and most reliable products for patients using cannabis for both medical purposes as well as recreational consumers."
"Medical Cannabis by Shoppers is best placed to offer Canadians the reassurance of medical products that have been tested and validated," said Ken Weisbrod, Vice President, Business Development/Cannabis Strategy, Shoppers Drug Mart. "Our development of a blockchain secured initiative with TruTrace has now been integrated into an operational portal that will provide products with an immutable digital identity that can capture everything from detailed chemistry down to its DNA."
The MC-RWE Study is a prospective, non-interventional, observational study to describe the benefits of medical cannabis for various common medical issues and seeks to enroll at least 2,000 subjects from across Canada who will be followed for 24 weeks. More on this study can be found here.
Greenlane Holdings, Inc. (NASDAQ: GNLN), one of the largest global sellers of premium cannabis accessories, child-resistant packaging, supply, and specialty vaporization products, announced today their partnership with NEO Plastics, an innovative packaging company providing an entirely new sustainable solution for discarded plastics. Available this July exclusively to Greenlane customers, NEO Packaging adds an environmentally-friendly offering to Greenlane’s existing packaging lines.
NEO Plastics supports landfill gas-to-energy efforts to enhance the end-of-life value of plastic packaging. NEO’s packaging contains an additive that accelerates the natural microbial digestion of the packaging’s material faster than standard plastic alternatives. During this process, biogases are released and can be collected and turned into clean, renewable energy which can be used to power communities.
“Sustainable packaging is in very high demand in the cannabis industry and we are proud to offer an environmentally-friendly alternative to our customers,” said Aaron LoCascio, Co-Founder and CEO of Greenlane Holdings. “NEO Plastics produces innovative and forward-thinking products that convert waste challenges into energy opportunities and we are excited to help them on their mission to spread awareness about the world’s environmental needs.”
NEO Packaging does not change the feel, form, or function of traditional mylar bags, allowing it to maintain its high-barrier properties. They are ASTM and CPSC child-resistant compliant with a concealed child-resistant zipper. The packaging will be available in six sizes ranging from a gram to a pound and come in two colors. A wide variety of made-to-order customization capabilities are available, including stateside and overseas printing and application enhancements. This product line is competitively priced at or below market prices of traditional mylar barrier bags.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) today announced that Curaleaf has completed the acquisition from Grassroots of exclusive rights to the Grassroots' All Rebels Rockers, Inc. marijuana license in Arizona. The transaction was completed in advance of the closing of Curaleaf's acquisition of Grassroots to enable accelerated development of the All Rebel Rockers license.
Curaleaf's acquisition of Grassroots itself is expected to close early next week, after the Grassroots shareholders meeting scheduled to approve the revised transaction on July 16.
Joseph Lusardi, CEO of Curaleaf, said, "Our acquisition of our 9th license in Arizona further strengthens our presence in the state, which continues to be one of the largest medical cannabis markets in the country. It also marks one of the final milestones before we formally close our acquisition of Grassroots."
Under this license Curaleaf will open its 9th store, as it currently operates eight dispensaries in Arizona and already has one of the largest retail footprints in the Metro Phoenix Area. Arizona is one of the largest medical marijuana markets in the U.S. with one of the highest percentages of registered patients.
The close of the acquisition of Grassroots will make Curaleaf the world's largest cannabis company by revenue and the most diversified, vertically integrated cannabis company in the United States, the world's largest cannabis market. The transaction expands Curaleaf's presence from 18 to 23 states, with the combined company having over 135 dispensary licenses, 89 operational dispensary locations, over 30 processing facilities and 22 cultivation sites with 1.6 million square feet of current cultivation capacity.
Horizons ETFs Management (Canada) Inc. has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) and the Horizons US Marijuana Index ETF (NEO: HMUS).
HMMJ seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. This index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry. The North American Marijuana Index selects from a current universe of companies that have operations that may include one or more offerings of biopharmaceuticals, medical manufacturing, distribution, bio-products and other ancillary businesses related to the marijuana industry. Securities within HMMJ's index generally have a market capitalization of greater than C$75 million.
"Following volatility that impacted nearly all asset classes across global markets in March, marijuana companies saw a strong recovery in the first two months of Q2 2020. HMMJ was up more than 15% for the three months ending at June 30, 2020," said Steve Hawkins, President and CEO of Horizons ETFs. "While there is volatility within the marijuana space again, the investing case remains strong: after Canadian adult-use cannabis sales set new record highs in March they remained consistently strong into April, reaching over $180 million."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
